Skip to main content
logo
Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.15
-0.12 (-2.28%)
Dec 4, 2025, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Novel Immunotherapies
7.69M
Log In
Log In
Log In
Log In
Upgrade
Novel Immunotherapies Growth
-2.36%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
7.69M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-2.36%
Log In
Log In
Log In
Log In
Upgrade